Jane Street Group, LLC Karuna Therapeutics, Inc. Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $1.1 Million - $2.16 Million	-6,808 Reduced 66.33%	3,456 $1.09 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $8.18 Million - $10.8 Million	-49,673 Reduced 82.88%	10,264 $1.74 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $10.6 Million - $14.4 Million	59,937 New	59,937 $13 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $2.54 Million - $3.14 Million	-13,243 Reduced 27.69%	34,581 $6.8 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $5.4 Million - $12.1 Million	43,659 Added 1048.24%	47,824 $10.8 Million

Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $5.4 Million - $12.1 Million	43,659 Added 1048.24%	47,824 $10.8 Million
Q2 2022 Aug 16, 2022	BUY	$93.97 - $143.33 $2,819 - $4,299	30 Added 0.73%	4,165 $527,000
Q1 2022 May 17, 2022	SELL	$98.9 - $132.37 $516,554 - $691,368	-5,223 Reduced 55.81%	4,135 $524,000
Q4 2021 Feb 15, 2022	BUY	$110.64 - $159.4 $266,642 - $384,154	2,410 Added 34.69%	9,358 $1.23 Million
Q4 2020 Feb 17, 2021	SELL	$75.23 - $109.23 $287,002 - $416,712	-3,815 Reduced 35.45%	6,948 $706,000
Q3 2020 Nov 17, 2020	SELL	$71.31 - $109.74 $2.18 Million - $3.36 Million	-30,604 Reduced 73.98%	10,763 $832,000
Q2 2020 Aug 17, 2020	BUY	$62.14 - $117.21 $2.57 Million - $4.85 Million	41,367 New	41,367 $4.61 Million
Q1 2020 May 15, 2020	SELL	$60.41 - $115.92 $644,755 - $1.24 Million	-10,673 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $122,099 - $1.32 Million	10,673 New	10,673 $804,000

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.